Functional diversity: update of the posttranslational modification of Epstein-Barr virus coding proteins
- PMID: 36376593
- PMCID: PMC11802978
- DOI: 10.1007/s00018-022-04561-2
Functional diversity: update of the posttranslational modification of Epstein-Barr virus coding proteins
Abstract
Epstein-Barr virus (EBV), a human oncogenic herpesvirus with a typical life cycle consisting of latent phase and lytic phase, is associated with many human diseases. EBV can express a variety of proteins that enable the virus to affect host cell processes and evade host immunity. Additionally, these proteins provide a basis for the maintenance of viral infection, contribute to the formation of tumors, and influence the occurrence and development of related diseases. Posttranslational modifications (PTMs) are chemical modifications of proteins after translation and are very important to guarantee the proper biological functions of these proteins. Studies in the past have intensely investigated PTMs of EBV-encoded proteins. EBV regulates the progression of the latent phase and lytic phase by affecting the PTMs of its encoded proteins, which are critical for the development of EBV-associated human diseases. In this review, we summarize the PTMs of EBV-encoded proteins that have been discovered and studied thus far with focus on their effects on the viral life cycle.
Keywords: Cell transformation; Epstein–Barr virus; Posttranslational modification; Viral replication; Virus life cycle.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Latent and lytic Epstein-Barr virus replication strategies.Rev Med Virol. 2005 Jan-Feb;15(1):3-15. doi: 10.1002/rmv.441. Rev Med Virol. 2005. PMID: 15386591 Review.
-
The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.J Virol. 2020 Aug 17;94(17):e01215-20. doi: 10.1128/JVI.01215-20. Print 2020 Aug 17. J Virol. 2020. PMID: 32581094 Free PMC article.
-
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.
-
Lytic cycle switches of oncogenic human gammaherpesviruses.Adv Cancer Res. 2007;97:81-109. doi: 10.1016/S0065-230X(06)97004-3. Adv Cancer Res. 2007. PMID: 17419942 Review.
-
Epstein-Barr virus regulates the life cycle and host cell biology by hijacking post-translational modification.Rev Med Virol. 2023 Jul;33(4):e2447. doi: 10.1002/rmv.2447. Epub 2023 Apr 8. Rev Med Virol. 2023. PMID: 37029718 Review.
Cited by
-
The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction.Clin Cancer Res. 2024 Nov 15;30(22):5207-5217. doi: 10.1158/1078-0432.CCR-24-1142. Clin Cancer Res. 2024. PMID: 39264275 Free PMC article.
-
EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma.Vaccines (Basel). 2025 Apr 29;13(5):478. doi: 10.3390/vaccines13050478. Vaccines (Basel). 2025. PMID: 40432090 Free PMC article. Review.
References
-
- Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 283:702–703. 10.1016/s0140-6736(64)91524-7 - PubMed
-
- Feederle R, Klinke O, Kutikhin A et al (2015) Epstein–Barr virus: from the detection of sequence polymorphisms to the recognition of viral types. Springer International Publishing, Berlin - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous